ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Outside U.S. realized price impact YoY [Q1–Q3 10-Q by Year
Outside U.S. realized price impact YoY (%) [Q1–Q3 10-Q & FY 10-K] (%)
Eli Lilly Outside U.S. realized price impact YoY [Q1–Q3 10-Q: -4.0% in FY2023, up 6.0 pts from a year earlier. No newer figure appears in the documents we track.
Where the FY2023 figure comes from
“|| Price | 9 | % | (4) | % | 4 | %”
Source: Form 10-K FY2023 (filed 2024-02-21) ↗
Reported in Form 10-Q / 10-K MD&A Revenue Growth Decomposition Table.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Outside U.S. realized price impact YoY (%) [Q1–Q3 10-Q & FY 10-K] (%) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | -4.0% | +6.0 pts | Form 10-K FY2023 (filed 2024-02-21) ↗ |
| FY2022 | Dec 31, 2022 | -10.0% | -6.0 pts | Form 10-K FY2022 (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | -4.0% | +2.0 pts | Form 10-K FY2021 (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | -6.0% | -5.0 pts | Form 10-K FY2020 (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | -1.0% | +2.0 pts | Form 10-K FY2019 (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | -3.0% | -2.0 pts | Form 10-K FY2018 (filed 2019-02-19) ↗ |
| FY2017 | Dec 31, 2017 | -1.0% | – | Form 10-K FY2017 (filed 2018-02-20) ↗ |
Cite this data
StockData. (2026). Eli Lilly Outside U.S. realized price impact YoY [Q1–Q3 10-Q (%), annual FY2017–FY2023 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/rev-growth-nonus-price
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.